Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

BUY
$109.52 - $120.96 $2,190 - $2,419
20 Added 0.49%
4,137 $470,000
Q4 2023

Jan 16, 2024

BUY
$90.19 - $110.4 $23,449 - $28,704
260 Added 6.74%
4,117 $453,000
Q3 2023

Nov 07, 2023

SELL
$95.53 - $114.62 $21,589 - $25,904
-226 Reduced 5.54%
3,857 $373,000
Q2 2023

Aug 11, 2023

BUY
$100.78 - $112.29 $28,823 - $32,114
286 Added 7.53%
4,083 $445,000
Q3 2022

Oct 19, 2022

SELL
$96.76 - $112.03 $9,192 - $10,642
-95 Reduced 2.44%
3,797 $367,000
Q2 2022

Jul 20, 2022

SELL
$102.07 - $123.37 $3,062 - $3,701
-30 Reduced 0.76%
3,892 $423,000
Q1 2022

Apr 19, 2022

SELL
$114.02 - $139.04 $2,508 - $3,058
-22 Reduced 0.56%
3,922 $464,000
Q4 2021

Mar 15, 2022

BUY
$115.53 - $141.46 $455,650 - $557,918
3,944 New
3,944 $555,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Security Financial Services, Inc. Portfolio

Follow Security Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Security Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Security Financial Services, Inc. with notifications on news.